HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management

M Lechner, J Liu, L Masterson, TR Fenton - Nature reviews Clinical …, 2022 - nature.com
Abstract Human papillomavirus (HPV)-positive (HPV+) oropharyngeal squamous cell
carcinoma (OPSCC) has one of the most rapidly increasing incidences of any cancer in high …

The changing therapeutic landscape of head and neck cancer

JD Cramer, B Burtness, QT Le, RL Ferris - Nature reviews Clinical …, 2019 - nature.com
Head and neck cancers are a heterogeneous collection of malignancies of the upper
aerodigestive tract, salivary glands and thyroid. In this Review, we primarily focus on the …

European white paper: oropharyngeal dysphagia in head and neck cancer

LWJ Baijens, M Walshe, LM Aaltonen, C Arens… - European Archives of …, 2021 - Springer
Abstract Purpose To develop a European White Paper document on oropharyngeal
dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the …

Recent advances and future directions in clinical management of head and neck squamous cell carcinoma

J Muzaffar, S Bari, K Kirtane, CH Chung - Cancers, 2021 - mdpi.com
Simple Summary Even with recent advances, there are urgent needs for novel therapies to
improve overall survival and decrease toxicities in the management of head and neck …

[HTML][HTML] Promising bioactivities of postbiotics: A comprehensive review

N Rafique, SY Jan, AH Dar, KK Dash, A Sarkar… - Journal of agriculture …, 2023 - Elsevier
Postbiotics are bioactive substances that are useful and are produced during fermentation in
the matrix. Postbiotics are under a fragile balance in our body, excessive metabolities, may it …

HPV-associated head and neck cancer

EE Vokes, N Agrawal, TY Seiwert - Journal of the National …, 2015 - academic.oup.com
Over the last two decades, it has been recognized that head and neck cancers, primarily in
the oropharynx, can be a distinct entity that is causally related to human papilloma virus …

Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review

V Budach, I Tinhofer - The Lancet Oncology, 2019 - thelancet.com
Current algorithms for the clinical management of patients with squamous cell carcinoma of
the head and neck (HNSCC) are based on a stage-dependent strategy where all patients at …

[HTML][HTML] De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?

P Golusinski, J Corry, V Vander Poorten, R Simo… - Oral oncology, 2021 - Elsevier
Human papilloma virus (HPV) is a well-established causative factor in a subset of squamous
cell carcinomas of the head and neck (HNSCC). Although HPV can be detected in various …

Comparison of survival after transoral robotic surgery vs nonrobotic surgery in patients with early-stage oropharyngeal squamous cell carcinoma

AT Nguyen, M Luu, J Mallen-St Clair, AC Mita… - JAMA …, 2020 - jamanetwork.com
Importance Transoral robotic surgery has been widely adopted since approval by the US
Food and Drug Administration in December 2009, despite limited comparative data …

Human papillomavirus in oropharyngeal cancer: The changing face of a disease

J Mallen-St Clair, M Alani, MB Wang… - Biochimica et Biophysica …, 2016 - Elsevier
The last decade has brought about an unexpected rise in oropharyngeal squamous cell
carcinoma (OPSCC) primarily in white males from the ages of 40–55 years, with limited …